SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (2453)4/18/1997 9:48:00 PM
From: John H. Farro   of 4342
 
Rick, I would very much like to see Dr. Babish back. As you said previously, he was the heart and soul of Paracelsian. However, I doubt that he can work miracles. The company has a major dilemma, they need to market AndroVir or else they will probably run out of funds by September. I doubt Dr. Babish will be able to change that and I don't think the company has money to test AndroVir sufficiently to meet the FDA's approval. However, he is a persuasive speaker and he is probably more thoroughly acquainted with the technology than anyone else. Maybe he can come up with a way short of conducting another phase of testing to convince the FDA to allow AndroVir on the market.

I don't know why Dr. Babish left, but my get feeling is that Paul is correct and that he was pushed out by Rhodes. If this is what happened then Rhodes' ego is probably too big to allow him to invite Babish back and he would be willing to take PRLN down rather than swallow his pride in inviting Babish back.

Robin M.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News